Ufp Technologies (UFPT) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.97% |
| Dec 31, 2025 | 20.10% |
| Sep 30, 2025 | 18.91% |
| Jun 30, 2025 | 17.12% |
| Mar 31, 2025 | 20.93% |
| Dec 31, 2024 | 23.47% |
| Sep 30, 2024 | 42.49% |
| Jun 30, 2024 | 24.80% |
| Mar 31, 2024 | 24.91% |
| Dec 31, 2023 | 25.76% |
| Sep 30, 2023 | 25.83% |
| Jun 30, 2023 | 26.37% |
| Mar 31, 2023 | 26.25% |
| Dec 31, 2022 | 26.07% |
| Sep 30, 2022 | 24.68% |
| Jun 30, 2022 | 26.54% |
| Mar 31, 2022 | 23.55% |
| Dec 31, 2021 | 20.79% |
| Sep 30, 2021 | 4.43% |
| Jun 30, 2021 | 3.97% |
| Mar 31, 2021 | 2.50% |
| Dec 31, 2020 | 13.71% |
| Sep 30, 2020 | 13.54% |
| Jun 30, 2020 | 13.84% |
| Mar 31, 2020 | 13.88% |
| Dec 31, 2019 | 13.84% |
| Sep 30, 2019 | 16.09% |
| Jun 30, 2019 | 15.98% |
| Mar 31, 2019 | 17.43% |
| Dec 31, 2018 | 16.59% |
| Sep 30, 2018 | 17.24% |
| Jun 30, 2018 | 17.80% |
| Mar 31, 2018 | 19.43% |
| Dec 31, 2017 | 7.09% |
| Sep 30, 2017 | 6.93% |
| Jun 30, 2017 | 7.08% |
| Mar 31, 2017 | 7.56% |
| Dec 31, 2016 | 6.84% |
| Sep 30, 2016 | 7.06% |
| Jun 30, 2016 | 7.03% |
| Mar 31, 2016 | 6.29% |
| Dec 31, 2015 | 6.65% |
| Sep 30, 2015 | 11.16% |
| Jun 30, 2015 | 12.14% |
| Mar 31, 2015 | 12.38% |
| Dec 31, 2014 | 12.18% |
| Sep 30, 2014 | 13.41% |
| Jun 30, 2014 | 13.35% |
| Dec 31, 2013 | 14.72% |